HIHR-9 Evaluationform | Healthy Ideas, Healthy Returns

Login

Home
HIHR events
Organisation
Contact

Select Page

Evaluation Form HIHR-9, November 2021

Your feedback to our 9th edition of HIHR would be much appreciated, under your own name or anonymously.
The questionnaire starts with an evaluation of each spin-off, followed by a few questions regarding the event itself.
We’re grateful for your input, which will help us to further optimize HIHR!

Evaluation Form HIHR-9 November 2021

Your name

Your organisation

Questions related to the individual pitches and quickfire sessions:

1. Did you join one or more PITCH sessions ? *

Yes

No

OtherOther

How did you appreciate the PITCH sessions ?

ShanX Medtech BV

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Cytomine

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Rapidemic

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Antares

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Preimure BV

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Haermonics

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

2. Did you join one or more QUICKFIRE sessions? *

Yes

No

OtherOther

How did you appreciate the QUICKFIRE sessions ?

Novel oligomeric multifunctional biologics

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

3D-FibroScreen

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

VUS Oncology

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Tumescence Measuring Wearable Patch

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Standing Sentinel / protoconsciousness bypass and training technologies

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Artificial Intelligence for coronary diagnostics

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

AIWorX

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

STEPS to recovery

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

How did you appreciate the QF-sessions in addition to their pitch?

ShanX Medtech BV

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Cytomine

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Preimure BV

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Antares

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

Rapidemic

1

2

3

4

5

6

7

8

9

10

1 = very poor, 10 = very good

Additional comments / recommendations

3. Questions related to the format of this HIHR-edition

Did you appreciate being offered the possibility to attend the EIT Health Investor Lounge session in the afternoon?

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Additional comments / recommendations

Does the combination with the Investor Lounge makes it more attractive for you to come?

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Additional comments / recommendations

How did you appreciate the F2F format of this edition?

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Additional comments / recommendations

Do you prefer F2F-editions / online editions / a combination of both ?

F2F-editions

On line editions

A combination of both

One input only, please

Additional comments / recommendations

How did you appreciate the online format of our Quickfire-sessions ?

1

2

3

4

5

6

7

8

9

10

1 = least likely, 10 = very likely

Additional comments / recommendations

Do you have any suggestions or ideas on the format of our future events ?

4. When deciding on attending HIHR (regardless of the format), which aspects do you consider? Please mark in order of importance:

Informal networking

1

2

3

4

5

1 = least important, 5 = most important

Travel time

1

2

3

4

5

1 = least important, 5 = most important

Opportunity to F2F meet investors / TTO-professionals / spin-off presenters

1

2

3

4

5

1 = least important, 5 = most important

Costs

1

2

3

4

5

1 = least important, 5 = most important

Chance to scout new potential investment opportunities

1

2

3

4

5

1 = least important, 5 = most important

Other, i.e.:

5. How did you appreciate the event overall?

Overall

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Organisation

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Content

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Set up

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Pitch sessions

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Quickfire sessions

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Conference venue - Level, Leiden

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Online facility for the pitch event

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Online facility for the Quickfire-sessions

1

2

3

4

5

6

7

8

9

10

1 = least appreciated, 10 = highly appreciated

Is this conference sufficiently relevant to your investment portfolio?

1

2

3

4

5

6

7

8

9

10

1 = not relevant, 10 = highly relevant

Based on the knowledge you gained from this event, to what extend would you recommend this event to others ?

1

2

3

4

5

6

7

8

9

10

1 = not recommended, 10 = highly recommended

Do you have any suggestions regarding the organisation of such future events (a.o. location/venue/online format, organisation, networking opportunities or on the selection of the presentations)?

6. Would you be interested in joining a HIHR LinkedIn group for investors and KTO-professionals?

Yes

No

OtherOther

Additional comments / recommendations

7. Do you have a quote that we may put on our website ?

Can we add your name to this?

Yes

No

OtherOther

8. Are there any other comments or suggestions you wish to add ?

Thank you for your feed back! We hope you've appreciated our event and look forward to welcoming you at the next edition of HIHR. HIHR-10 will take place on Wednesday June 1, Belgium (t.b.c.)

If you are human, leave this field blank.

45 Participating academic institutions in the Benelux (not all logos included)

Radboud umc

Wageningen University & Research

Preferred partner

Silver partners

HIHR supporters

Bioqube Ventures

For any inquiries on HIHR please contact:

Claar-els van Delft
Email: claar-els@hihr.eu
Mobile phone: +31 (0)6 2848 0549

©2021 HIHR